GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GT Biopharma GTBP · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.32

-2.26%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on GT Biopharma

Our reporting

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -2.50 a share.

Past results

Reported against what analysts expected

14 Aug 202613 Aug 202615 May 20262 Mar 202614 Nov 202514 Aug 2025
Earnings per share-3.00-0.55-0.11-2.22-0.83-0.55
Forecast-2.00-0.08-0.08-0.22-0.38-0.68

Key events

  1. 8 Sept 202625-to-1 reverse split
  2. 5 Feb 202430-to-1 reverse split
  3. 11 Feb 202117-to-1 reverse split
  4. 21 Aug 2017300-to-1 reverse split
  5. 15 Dec 2015250-to-1 reverse split
  6. 22 Oct 2013Listed

GT Biopharma in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.